Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Financial Management Professionals Inc.

Financial Management Professionals Inc. lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.2% in the 1st quarter, Holdings Channel.com reports. The firm owned 1,695 shares of the medical equipment provider’s stock after selling 75 shares during the quarter. Financial Management Professionals Inc.’s holdings in Intuitive Surgical were worth $839,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Norges Bank purchased a new stake in shares of Intuitive Surgical during the fourth quarter worth about $2,401,493,000. GAMMA Investing LLC boosted its stake in Intuitive Surgical by 54,010.7% during the first quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider’s stock worth $14,999,630,000 after buying an additional 3,022,979 shares during the last quarter. Proficio Capital Partners LLC grew its holdings in shares of Intuitive Surgical by 89,098.8% in the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after purchasing an additional 948,902 shares during the period. Capital Research Global Investors increased its holdings in shares of Intuitive Surgical by 25.5% during the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider’s stock worth $1,764,904,000 after buying an additional 687,906 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in Intuitive Surgical during the fourth quarter worth $313,769,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

ISRG stock opened at $551.85 on Wednesday. The company has a market cap of $197.79 billion, a price-to-earnings ratio of 86.09, a price-to-earnings-growth ratio of 5.85 and a beta of 1.67. The company has a fifty day moving average price of $518.20 and a 200 day moving average price of $538.82. Intuitive Surgical, Inc. has a 12 month low of $397.47 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. The business had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.19 billion. During the same period in the prior year, the company earned $1.50 earnings per share. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of research analyst reports. BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the company a “buy” rating in a research note on Monday, April 14th. Royal Bank of Canada dropped their price objective on shares of Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Barclays cut their price target on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating on the stock in a research note on Thursday, April 24th. Truist Financial lowered their price objective on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research report on Wednesday, April 23rd. Finally, Erste Group Bank lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 17th. Five research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $596.05.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Brian Edward Miller sold 8,900 shares of the company’s stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the transaction, the executive vice president now owns 5,758 shares in the company, valued at approximately $2,793,033.06. This represents a 60.72% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 489 shares of Intuitive Surgical stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $533.18, for a total transaction of $260,725.02. Following the completion of the sale, the senior vice president now directly owns 2,091 shares in the company, valued at approximately $1,114,879.38. The trade was a 18.95% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 25,286 shares of company stock worth $12,594,546 in the last quarter. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.